Method for treating schizophrenia
OwnerMichael J. Kinneyinventor
Life of this patent
Estimating the term…
Abstract
A method for treating schizophrenia in human patients by hemoperfusion using hemoperfusion of the patient's blood through a charcoal cartridge in a manner for selective removal of molecules is disclosed. The method may use known hemoperfusion cartridges for a heretofore completely unappreciated application and has the advantages of lesser side effects and easier implementation than other known methods of treatment.
Claims9
The method of treating schizophrenia in a human patient using a sterile activated carbon medium perfusion filter, comprising the steps of
- (a) forming an extracorporeal blood circulation path from the patient to and through the activated carbon medium filter and back to the patient;
- (b) circulating blood from the patient through that path for a period of time sufficient to capture in the activated carbon medium filter a significant quantity of molecules from the patient's blood, and returning the blood to the patient;
- and
- (c) repeating the above steps at intervals until the schizophrenic symptoms are lessened, and
- whereby a temporary improvement in the patient's condition may be achieved.
The method of treating schizophrenia in a human patient using a sterile activated medium hemoperfusion cartridge, comprising the steps of
- (a) forming an extracorporeal blood circulation path from the patient to and through the hemoperfusion cartridge and back to the patient;
- (b) circulating the blood from the patient through that path for a period of time to capture in the cartridge molecules that may represent abnormal metabolites in the patient's blood and returning the cleansed blood to the patient;
- and
- (c) repeating the above steps at intervals until the schizophrenic symptoms are temporarily improved following such treatment.
The method of treating schizophrenia in a human patient using a sterile activated carbon medium perfusion filter, comprising the steps of
- (a) forming an extracorporeal blood circulation path from the patient to and through the activated carbon medium filter and back to the patient;
- (b) circulating blood from the patient through that path for a period of time and returning the filtered blood to the patient;
- and
- (c) repeating the above steps at intervals until the schizophrenic symptoms are lessened;
- and
- whereby the patient's schizophrenia is at least temporarily improved.
Dependencies are inferred from the claim text.